Marie ENGMAN

Enfermero Titulado
Suecia
Specialist for the applications of derma fillers. Working as independent Clinical Trainer in the field of aesthetic dermatology within more than 20 years of experience and a certificate form Karolinska hospital in Stockholm, Sweden.
leer más
add item Agregar Marie ENGMAN

Marie ENGMAN's informes (2)

Molecular characterization of PRM-associated endometrial changes, PAEC, following mifepristone treatment.

10, 2018

The progesterone receptor modulator (PRM) mifepristone holds the potential to be developed for regular contraception. However, long-term treatment can cause thickening of the endometrium and PRM-associated endometrial changes (PAEC). The objective of this study was to explore the molecular expression of endometrium displaying PAEC after mifepristone treatment in order to understand the future implications of PAEC and safety of long-term use. leer más

Contraception

Mesenchymal Stromal Cells Support Endometriotic Stromal Cells .

2018

Endometriosis is an inflammatory disease marked by ectopic growth of endometrial cells. Mesenchymal stromal cells (MSC) have immunosuppressive properties that have been suggested as a treatment for inflammatory diseases. Therefore, the aim herein was to examine effects of allogeneic MSC on endometriosis-derived cells as a potential therapy for endometriosis. MSC from allogeneic adipose tissue (Ad-MSC) and stromal cells from endometrium (ESC) and endometriotic ovarian cysts (ESC) from women with endometriosis were isolated. The effects of Ad-MSC on ESC and ESC were investigated using proliferation, apoptosis, adhesion, tube formation, migration, and invasion assays. Ad-MSC significantly increased proliferation of ESC compared to untreated controls. Moreover, Ad-MSC significantly decreased apoptosis and increased survival of ESC. Ad-MSC significantly increased adhesion of ESC and not ESC on fibronectin. Conditioned medium from cocultures of Ad-MSC and ESC significantly increased tube formation of human umbilical vein endothelial cells on matrigel. Ad-MSC may significantly increase migration of ESC and did not increase invasion of both cell types. The data suggest that allogeneic Ad-MSC should not be considered as a potential therapy for endometriosis, because they may support the pathology by maintaining and increasing growth of ectopic endometrial tissue. leer más

Stem cells international

intereses de Marie ENGMAN